Trials / Completed
CompletedNCT03157583
A Study to Measure the Sun Protection Factor (SPF) and Ultraviolet-A Protection Factor (UVAPF) of Four Developmental Sunscreen Formulations
Determination of the Sun Protection Factor (SPF) and in Vitro UVA Protection Factor (UVAPF) of Four Developmental Sunscreen Formulations
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine the SPF and UVAPF of four sunscreen formulations using international standard methodologies ISO24444:2010 for SPF and ISO24443:2012 for UVAPF.
Detailed description
This study consist of two steps. Step 1: determination of the SPF of the test products which will be performed as a single-center, randomized, evaluator blind, intra-individual comparison, no treatment and positive controlled clinical study as per ISO24444:2010. And Step 2: determination of the UVAPF of the test products which will be performed as a single center, open-label, negative and positive controlled technical test as per ISO24443:2012 (using test plates for assessing UV transmittance of four developmental sunscreens).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | NGBUV000A, (Expected SPF 30) | A total of 2.0 ± 0.05 mg/cm2 (milligram per centimeter square of test site area) NGBUV000A (test product 1) will be spread at the topical test sites on the back of each participant. And a total of 1.3 mg/cm2 of test product 1 will be applied to the test plates. |
| OTHER | NGBUV000B, (Expected SPF 30) | A total of 2.0 ± 0.05 mg/cm2 NGBUV000B (test product 2) will be spread at the topical test sites on the back of each participant. And a total of 1.3 mg/cm2 of test product 2 will be applied to the test plates. |
| OTHER | NGBUV000C, (Expected SPF 30) | A total of 2.0 ± 0.05 mg/cm2 NGBUV000C (test product 3) will be spread at the topical test sites on the back of each participant. And a total of 1.3 mg/cm2 of test product 3 will be applied to the test plates. |
| OTHER | NGBUV000D, (Expected SPF 30) | A total of 2.0 ± 0.05 mg/cm2 NGBUV000D (test product 4) will be spread at the topical test sites on the back of each participant. And a total of 1.3 mg/cm2 of test product 4 will be applied to the test plates. |
| OTHER | P3 Standard, (Expected SPF 16) | A total of 2.0 ± 0.05 mg/cm2 reference P3 standard will be spread at the topical test sites on the back of each participant. |
| OTHER | Sunscreen formulation S2 | A total of 1.3 mg/cm2 of sunscreen formulation S2 will be applied to the test plates. |
| OTHER | Glycerin | A total of 1.3 mg/cm2 of glycerin will be applied to the test plates. |
Timeline
- Start date
- 2017-06-21
- Primary completion
- 2017-07-07
- Completion
- 2017-07-07
- First posted
- 2017-05-17
- Last updated
- 2019-07-22
- Results posted
- 2019-07-22
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT03157583. Inclusion in this directory is not an endorsement.